Stockscreener 앱 받기
0.762
4.75%
-0.038
시장 영업 전:
.77
0.008
+1.05%
전일 마감가:
$0.80
열려 있는:
$0.8
하루 거래량:
383.98K
Relative Volume:
0.42
시가총액:
$14.92M
수익:
$1.89M
순이익/손실:
$-17.92M
주가수익비율:
-0.1139
EPS:
-6.69
순현금흐름:
$-15.62M
1주 성능:
-14.20%
1개월 성능:
-3.34%
6개월 성능:
-49.20%
1년 성능:
-66.13%
1일 변동 폭
$0.76
$0.8036
1주일 범위
$0.76
$0.8616
52주 변동 폭
$0.633
$2.31
Longeveron Inc Stock (LGVN) Company Profile
명칭
Longeveron Inc
전화
305-302-7158
주소
1951 NW 7TH AVENUE, MIAMI
LGVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.762 | 16.85M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.00 | 107.10B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.19 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.56 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
832.35 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.88 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | ROTH MKM | Buy |
Longeveron Inc 주식(LGVN)의 최신 뉴스
Longeveron Inc. Earnings Call: Mixed Sentiments Amid Clinical Progress - TipRanks
Will Longeveron Inc. stock remain a Wall Street favoriteJuly 2025 Short Interest & Smart Allocation Stock Reports - fcp.pa.gov.br
Key facts: Longeveron anticipates pivotal trial results in 2026; Q3 expenses at $7.435M - TradingView
Visualizing Longeveron Inc. stock with heatmaps2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com
Why analysts upgrade Longeveron Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Can you recover from losses in Longeveron Inc.Earnings Growth Report & Low Risk Entry Point Guides - newser.com
Longeveron Inc. Reports Q3 2025 Financial Results - TipRanks
Transcript : Longeveron Inc., Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener
Longeveron Posts Bigger Losses But Analysts Still See Upside - Finimize
Longeveron reports Q3 EPS (39c), consensus (26c) - TipRanks
Cellular therapy developer Longeveron's Q3 net loss widens - MarketScreener
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times
[8-K] Longeveron Inc. Reports Material Event | LGVN SEC FilingForm 8-K - Stock Titan
Is Longeveron Inc. stock in correction or buying zoneJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Longeveron Inc. (LGVN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Longeveron Inc. (LGVN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2025 Result - GuruFocus
Is it too late to sell Longeveron Inc.July 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
What dividend safety score for Longeveron Inc. stockJuly 2025 News Drivers & AI Forecast Swing Trade Picks - newser.com
What data driven models say about Longeveron Inc.’s futureWeekly Investment Summary & Low Volatility Stock Recommendations - newser.com
How to recover losses in Longeveron Inc. stockCEO Change & Long-Term Capital Growth Strategies - newser.com
What analysts say about Longeveron Inc stockBullish Engulfing Patterns & Free Dashboard to Track Market Momentum - earlytimes.in
How Longeveron Inc. stock compares to growth peersPortfolio Value Report & Proven Capital Preservation Methods - fcp.pa.gov.br
Will Longeveron Inc. stock continue dividend increasesWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 - The Manila Times
Longeveron Inc (LGVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.82%
1.34%
자본화:
|
볼륨(24시간):